Second young epilepsy patient in S’pore gets nod to use medical cannabis

SINGAPORE – Approval to use cannabis-derived medication has been granted to a second person in Singapore.

The “young patient” who has treatment-resistant epilepsy was allowed to use a cannabinoid pharmaceutical, commonly known as medical cannabis, following an application after December 2019, the Ministry of Home Affairs (MHA) said in response to queries from The Straits Times.

Please subscribe or log in to continue reading the full article.

Get unlimited access to all stories at $0.99/month

  • Latest headlines and exclusive stories
  • In-depth analyses and award-winning multimedia content
  • Get access to all with our no-contract promotional package at only $0.99/month for the first 3 months*

*Terms and conditions apply.

Join ST’s Telegram channel here and get the latest breaking news delivered to you.

Source: Read Full Article